Konkayeva, M.; Kadralinova, A.; Zhanarystan, N.; Akhatov, N.; Konkayev, A.
Case Report: High-Dose Ferric Carboxymaltose as an Antianaemic Agent to Avoid Haemotransfusions after Total Hip Replacement. Medicina 2024, 60, 1274.
https://doi.org/10.3390/medicina60081274
AMA Style
Konkayeva M, Kadralinova A, Zhanarystan N, Akhatov N, Konkayev A.
Case Report: High-Dose Ferric Carboxymaltose as an Antianaemic Agent to Avoid Haemotransfusions after Total Hip Replacement. Medicina. 2024; 60(8):1274.
https://doi.org/10.3390/medicina60081274
Chicago/Turabian Style
Konkayeva, Maiya, Assiya Kadralinova, Nazerke Zhanarystan, Nurlan Akhatov, and Aidos Konkayev.
2024. "Case Report: High-Dose Ferric Carboxymaltose as an Antianaemic Agent to Avoid Haemotransfusions after Total Hip Replacement" Medicina 60, no. 8: 1274.
https://doi.org/10.3390/medicina60081274
APA Style
Konkayeva, M., Kadralinova, A., Zhanarystan, N., Akhatov, N., & Konkayev, A.
(2024). Case Report: High-Dose Ferric Carboxymaltose as an Antianaemic Agent to Avoid Haemotransfusions after Total Hip Replacement. Medicina, 60(8), 1274.
https://doi.org/10.3390/medicina60081274